SILVER SPRING
Bimatoprost grenod NDA accepted for glaucoma, OHT
- Drug
- bimatoprost grenod
- Indication
- open-angle glaucoma and ocular hypertension
FDA accepted a New Drug Application for bimatoprost grenod for the treatment of open-angle glaucoma and ocular hypertension.
What this means
Bimatoprost grenod is an eye drop that lowers high pressure inside the eye, a condition that can lead to glaucoma. The FDA has accepted a new drug application to review this treatment for open-angle glaucoma and ocular hypertension. If approved, it would provide a new option for patients who need to control their eye pressure to prevent vision loss.